UNITEDHEALTH GROUP INC - Common Stock (UNH)

Historical Holders from Q1 2014 to Q3 2025

Symbol
UNH on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
911M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
732M
Holdings value
$253B
% of all portfolios
0.186%
Grand Portfolio weight change
-0.02%
Number of holders
3105
Number of buys
1546
Number of sells
-1600
Average Value change %
-0.01%
Average buys %
+0.051%
Average sells %
-0.058%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of UNITEDHEALTH GROUP INC - Common Stock (UNH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10.08% $38.4B 91.8M The Vanguard Group 30 Apr 2025

Institutional Holders of UNITEDHEALTH GROUP INC - Common Stock (UNH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 732M $253B -$12.7B $345.30 3,105
2025 Q2 772M $241B -$10.6B $311.97 3,130
2025 Q1 798M $418B -$5.45B $523.75 3,567
2024 Q4 807M $408B -$2.86B $505.86 3,642
2024 Q3 808M $473B +$537M $584.68 3,438
2024 Q2 807M $411B +$3.7B $509.26 3,373
2024 Q1 804M $398B -$3.6B $494.70 3,353
2023 Q4 812M $427B +$1.27B $526.47 3,398
2023 Q3 807M $407B +$29.8M $504.19 3,124
2023 Q2 807M $388B -$2.01B $480.64 3,114
2023 Q1 808M $382B -$4.02B $472.59 3,088
2022 Q4 821M $435B +$1.64B $530.18 3,132
2022 Q3 819M $414B -$2.86B $505.04 2,979
2022 Q2 821M $422B +$3.84B $513.63 2,942
2022 Q1 819M $418B -$1.92B $509.97 2,945
2021 Q4 822M $413B +$338M $502.14 2,881
2021 Q3 821M $321B -$553M $390.74 2,551
2021 Q2 823M $329B -$386M $400.44 2,572
2021 Q1 825M $307B -$977M $372.07 2,499
2020 Q4 827M $290B -$466M $350.68 2,452
2020 Q3 828M $258B -$1.38B $311.77 2,225
2020 Q2 831M $245B +$947M $294.95 2,198
2020 Q1 829M $207B -$903M $249.38 2,111
2019 Q4 831M $244B +$4.26B $293.98 2,141
2019 Q3 818M $178B -$680M $217.32 1,919
2019 Q2 820M $200B +$2.19B $244.01 1,958
2019 Q1 823M $203B -$1.65B $247.26 1,935
2018 Q4 829M $206B -$232M $249.12 1,912
2018 Q3 830M $221B -$343M $266.04 1,778
2018 Q2 831M $204B +$1.08B $245.34 1,748
2018 Q1 826M $177B -$2.98B $214.00 1,689
2017 Q4 841M $185B -$844M $220.46 1,670
2017 Q3 843M $165B +$408M $195.85 1,512
2017 Q2 846M $157B +$1.53B $185.42 1,483
2017 Q1 837M $137B +$12.6B $164.01 1,444
2016 Q4 830M $133B -$303M $160.04 1,409
2016 Q3 828M $116B +$306M $140.00 1,268
2016 Q2 826M $117B -$1.46B $141.20 1,255
2016 Q1 836M $108B -$306M $128.90 1,207
2015 Q4 837M $98.5B -$436M $117.64 1,214
2015 Q3 840M $97.5B +$1.39B $116.01 1,189
2015 Q2 832M $101B -$318M $122.00 1,193
2015 Q1 833M $98.5B -$1.35B $118.29 1,152
2014 Q4 847M $85.7B -$827M $101.09 1,097
2014 Q3 854M $73.6B -$1.18B $86.25 964
2014 Q2 866M $70.8B -$570M $81.75 958
2014 Q1 875M $71.7B +$628M $81.99 945